Showing results (81-90 of 207) with videos related to
Sort By:
Pageof 21
The Keio Journal of Medicine|August 4, 2005
The Sasagawa project: a model for deinstitutionalisation in JapanMasafumi Mizuno, Kei Sakuma, Yonosuke Ryu, et al.Journal of Cardiovascular Electrophysiology|March 14, 2018
Differences in activated clotting time and initial heparin dosage during atrial fibrillation ablation for patients with edoxaban compared with warfarinHirosuke Yamaji, Takashi Murakami, Kazuyoshi Hina, et al.Clinical Drug Investigation|April 11, 2013
Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablationHirosuke Yamaji, Takashi Murakami, Kazuyoshi Hina, et al.Journal of Cardiovascular Electrophysiology|November 9, 2019
Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomesHirosuke Yamaji, Takashi Murakami, Kazuyoshi Hina, et al.Immunity|October 14, 2008
Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 inductionHideki Ogura, Masaaki Murakami, Yuko Okuyama, et al.Open Heart|August 2, 2017
Adjunctive interpulmonary isthmus ablation has no added effects on atrial fibrillation recurrenceShunichi Higashiya, Hirosuke Yamaji, Takashi Murakami, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 6, 2023
IN.PACT AV access randomized trial: Japan cohort outcomes through 12 monthsHiroaki Haruguchi, Kotaro Suemitsu, Naoko Isogai, et al.Journal of Cardiovascular Pharmacology|September 10, 2019
Effects of Oral Anticoagulants on Patients With Atrial Fibrillation Aged 90 Years and Older: Comparison Among Direct Oral Anticoagulant, Warfarin Anticoagulant, and NonanticoagulationHirosuke Yamaji, Shunichi Higashiya, Takashi Murakami, et al.Journal of Cardiovascular Pharmacology|February 8, 2017
Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial FibrillationHirosuke Yamaji, Takashi Murakami, Kazuyoshi Hina, et al.The Australian and New Zealand Journal of Psychiatry|May 11, 2006
Deinstitutionalization of long-stay patients with schizophrenia: the 2-year social and clinical outcome of a comprehensive intervention program in JapanYonosuke Ryu, Masafumi Mizuno, Kei Sakuma, et al.Pageof 21